ALTACE (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the ALTACE drug offered from Pfizer Laboratories Div Pfizer Inc. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | ramipril |
| SUBSTANCE NAME: | RAMIPRIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1991-01-28 |
| END MARKETING DATE: | 0000-00-00 |
ALTACE HUMAN PRESCRIPTION DRUG Details:
| Item Description | ALTACE from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.25(mg/1) |
| START MARKETING DATE: | 1991-01-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61570-110_15516862-2de9-47d8-b385-4d3ff77fb4de |
| PRODUCT NDC: | 61570-110 |
| APPLICATION NUMBER: | NDA019901 |
Other RAMIPRIL Pharmaceutical Manufacturers / Labelers:
